Get started
REVIVE THERAPEUTICS LTDREVIVE THERAPEUTICS LTDREVIVE THERAPEUTICS LTD

REVIVE THERAPEUTICS LTD

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

31R chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪6.07 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.01EUR
Net income (FY)
‪−4.37 M‬EUR
Revenue (FY)
—
Shares float
‪351.53 M‬
Beta (1Y)
0.01

About REVIVE THERAPEUTICS LTD.

Sector
Health Technology
CEO
Michael Frank
Headquarters
Toronto
Website
revivethera.com
Founded
2012
Revive Therapeutics Ltd. engages in the research, development, and commercialization of drugs for disorders and infectious diseases. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Toronto, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 31R is 0.03 EUR — it hasn't changed in the past 24 hours. Watch REVIVE THERAPEUTICS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange REVIVE THERAPEUTICS LTD stocks are traded under the ticker 31R.
REVIVE THERAPEUTICS LTD is going to release the next earnings report on May 27, 2024. Keep track of upcoming events with our Earnings Calendar.
31R stock is 0% volatile and has beta coefficient of 0.01. Track REVIVE THERAPEUTICS LTD stock price on the chart and check out the list of the most volatile stocks — is REVIVE THERAPEUTICS LTD there?
Yes, you can track REVIVE THERAPEUTICS LTD financials in yearly and quarterly reports right on TradingView.
31R stock hasn't changed in a week, the month change is a 45.00% rise, over the last year REVIVE THERAPEUTICS LTD has showed a 36.96% decrease.
31R net income for the last quarter is ‪−526.79 K‬ EUR, while the quarter before that showed ‪−272.01 K‬ EUR of net income which accounts for −93.67% change. Track more REVIVE THERAPEUTICS LTD financial stats to get the full picture.
Today REVIVE THERAPEUTICS LTD has the market capitalization of ‪6.07 M‬, it has increased by 19.32% over the last week.
No, 31R doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 31R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REVIVE THERAPEUTICS LTD stock right from TradingView charts — choose your broker and connect to your account.
31R reached its all-time high on Dec 15, 2020 with the price of 0.58 EUR, and its all-time low was 0.0002 EUR and was reached on Oct 9, 2023. View more price dynamics on 31R chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REVIVE THERAPEUTICS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REVIVE THERAPEUTICS LTD stock shows the sell signal. See more of REVIVE THERAPEUTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.